Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Holt

Showing results (701-710 of 750) with videos related to

Pageof 75
Sort By:
The Lancet. Gastroenterology & Hepatology|December 10, 2021
Intensive drug therapy versus standard drug therapy for symptomatic intestinal Crohn's disease strictures (STRIDENT): an open-label, single-centre, randomised controlled trialJulien D Schulberg, Emily K Wright, Bronte A Holt, et al.
International Journal of Molecular Sciences|March 29, 2023
Immune Activation following Irbesartan Treatment in a Colorectal Cancer Patient: A Case StudyE Titmuss, K Milne, M R Jones, et al.
International Journal of Molecular Sciences|November 27, 2024
Correction: Titmuss et al. Immune Activation Following Irbesartan Treatment in a Colorectal Cancer Patient: A Case Study. <i>Int. J. Mol. Sci.</i> 2023, <i>24</i>, 5869E Titmuss, K Milne, M R Jones, et al.
Journal of Medicinal Chemistry|September 19, 2019
Discovery of GSK3527497: A Candidate for the Inhibition of Transient Receptor Potential Vanilloid-4 (TRPV4)Carl A Brooks, Linda S Barton, David J Behm, et al.
Blood|June 10, 2016
XLF deficiency results in reduced N-nucleotide addition during V(D)J recombinationHanna IJspeert, Jacob Rozmus, Klaus Schwarz, et al.
Nature Communications|November 12, 2017
The North American bullfrog draft genome provides insight into hormonal regulation of long noncoding RNAS Austin Hammond, René L Warren, Benjamin P Vandervalk, et al.
Molecular Cell|November 17, 2023
CDK4/6 inhibitor-mediated cell overgrowth triggers osmotic and replication stress to promote senescenceLisa Crozier, Reece Foy, Rozita Adib, et al.
ACS Medicinal Chemistry Letters|July 24, 2018
Reverse Hydroxamate Inhibitors of Bone Morphogenetic Protein 1Lara S Kallander, David Washburn, Mark A Hilfiker, et al.
Molecular Therapy. Methods & Clinical Development|April 25, 2014
Targeted CNS Delivery Using Human MiniPromoters and Demonstrated Compatibility with Adeno-Associated Viral VectorsCharles N de Leeuw, Frank M Dyka, Sanford L Boye, et al.
Oncoimmunology|April 30, 2024
Immune checkpoint therapy responders display early clonal expansion of tumor infiltrating lymphocytesJoel Kidman, Rachael M Zemek, John-William Sidhom, et al.
Pageof 75

Showing results (701-710 of 750) with videos related to

Sort By:
Pageof 75
The Lancet. Gastroenterology & Hepatology|December 10, 2021
Intensive drug therapy versus standard drug therapy for symptomatic intestinal Crohn's disease strictures (STRIDENT): an open-label, single-centre, randomised controlled trialJulien D Schulberg, Emily K Wright, Bronte A Holt, et al.
International Journal of Molecular Sciences|March 29, 2023
Immune Activation following Irbesartan Treatment in a Colorectal Cancer Patient: A Case StudyE Titmuss, K Milne, M R Jones, et al.
International Journal of Molecular Sciences|November 27, 2024
Correction: Titmuss et al. Immune Activation Following Irbesartan Treatment in a Colorectal Cancer Patient: A Case Study. <i>Int. J. Mol. Sci.</i> 2023, <i>24</i>, 5869E Titmuss, K Milne, M R Jones, et al.
Journal of Medicinal Chemistry|September 19, 2019
Discovery of GSK3527497: A Candidate for the Inhibition of Transient Receptor Potential Vanilloid-4 (TRPV4)Carl A Brooks, Linda S Barton, David J Behm, et al.
Blood|June 10, 2016
XLF deficiency results in reduced N-nucleotide addition during V(D)J recombinationHanna IJspeert, Jacob Rozmus, Klaus Schwarz, et al.
Nature Communications|November 12, 2017
The North American bullfrog draft genome provides insight into hormonal regulation of long noncoding RNAS Austin Hammond, René L Warren, Benjamin P Vandervalk, et al.
Molecular Cell|November 17, 2023
CDK4/6 inhibitor-mediated cell overgrowth triggers osmotic and replication stress to promote senescenceLisa Crozier, Reece Foy, Rozita Adib, et al.
ACS Medicinal Chemistry Letters|July 24, 2018
Reverse Hydroxamate Inhibitors of Bone Morphogenetic Protein 1Lara S Kallander, David Washburn, Mark A Hilfiker, et al.
Molecular Therapy. Methods & Clinical Development|April 25, 2014
Targeted CNS Delivery Using Human MiniPromoters and Demonstrated Compatibility with Adeno-Associated Viral VectorsCharles N de Leeuw, Frank M Dyka, Sanford L Boye, et al.
Oncoimmunology|April 30, 2024
Immune checkpoint therapy responders display early clonal expansion of tumor infiltrating lymphocytesJoel Kidman, Rachael M Zemek, John-William Sidhom, et al.
Pageof 75